Annual report pursuant to Section 13 and 15(d)

Investment (Tables)

v3.21.4
Investment (Tables)
12 Months Ended
Sep. 30, 2021
Investment  
Schedule of carrying value of the Company's total investment in DepYmed

As of September 30, 

    

2021

    

2020

Carrying value of DepYmed common shares

$

$

224,537

Fair value of DepYmed preferred shares assumed in connection with acquisition of Ohr

99,020

 

99,020

DepYmed preferred shares received in sale of intellectual property

316,724

Total Investment

$

415,744

$

323,557